Myasthenia Gravis PBMC
About: Myasthenia Gravis PBMC samples are collected from clinically confirmed Myasthenia Gravis (MG) donors and cryopreserved. These PBMCs are ideal for investigating autoreactive T and B cells, cytokine profiles, and the mechanism of MG-related antibody production.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 75192 | Myasthenia Gravis | 10M | Caucasian | 65 | Male |
VYVGART IV infusion, scheduled every week CellCept 1500mg BID Prednisone 5mg QD Ibuprofen 400 mg BID PRN omeprazole 20mg QD
|
8 | $765.00 | ||
| 77671 | Myasthenia Gravis | 10M | Caucasian | 37 | Female |
Vyvgart infusions Mestinon 60mg 5 times daily Lyrica 100mg 3 times daily Wellbutrin 150 QD Citalopram (Celexa) 20mg omeprazole 40mg QD Otezla 30mg twice daily Symbicort inhaler 1 puff twice daily Nurtec for migraines PRN albuterol inhaler PRN birth control pill Prednisone 5 MG medical marijuana
|
10 | $765.00 | ||
| 77579 | Myasthenia Gravis | 10M | Caucasian | 54 | Male |
Vyvgart injections – Every other Monday Pepcid OTC QD CellCept 1000 mg BID Simvastatin 10 mg QD Prednisone 10 mg Tapering schedule Mestinon 60 mg QD Aspirin 81 mg Every other day Vitamin C – Daily Fish Oil – Daily Vitamin D – Daily Potassium – Daily
|
4 | $765.00 | ||
| 75385 | Myasthenia Gravis | 10M | Caucasian | 37 | Female |
Vyvgart infusions Mestinon 60mg 5 times daily Lyrica 100mg 3 times daily Wellbutrin 150 QD Citalopram (Celexa) 20mg omeprazole 40mg QD Otezla 30mg twice daily Symbicort inhaler 1 puff twice daily Nurtec for migraines PRN albuterol inhaler PRN birth control pill Cellcept 500 mg BID medical marijuana
|
1 | $765.00 | ||
| 77426 | Myasthenia Gravis | 10M | Caucasian | 33 | Female |
(IV infusion treatments- IVIG & Soliris: get at Ivx heath) **IV bard power port needle 3/4ths** *Soliris IV 1200 mg: 1 day every other week (started 10/20/2020) Vvygart Infusion start 2/9/26, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Prednisone 10 mg: 5 in morning *Emgality: once a month on the 9th. (Started 5/9/2023) *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning --As Needed Meds-- *Ubrelvy mg: as needed -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed Eye gel lubricant drops- 3 times a day *Retin-A (tretinoin) cream 0.1%: at night every few days as tolerated where acne is *Clindamycin Phosphate Topical solution USP, 1%: Put on back, chest and shoulders once in morning, once at night *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed
|
4 | $765.00 | ||
| 70830 | Myasthenia Gravis | 10M | Hispanic/Latino | 66 | Male |
Mestinon/60mg/TID Escitalopran/10mg/QD
|
1 | $765.00 | ||
| 70794 | Myasthenia Gravis | 10M | Caucasian | 64 | Male |
Guanfacine 0.5mg QPM Zoloft 25mg QD anxiety Ropinirole 0.5mg RLS
|
3 | $765.00 | ||
| 76882 | Myasthenia Gravis | 50M | Caucasian | 65 | Male |
Mycophenolate 500mg 2 in the morning - 2 in the evening
|
75 | $1,208.00 | ||
| 70899 | Myasthenia Gravis | 50M | Asian/Pacific Islander | 71 | Female |
Escitalopram 10mg 1/day Mycophenolate Mofetil 250mg 4/day amlodipine 5mg 1/day Losartan 50mg 1/day
|
59 | $1,208.00 | ||
| 74488 | Myasthenia Gravis | 50M | Caucasian | 65 | Male |
Mycophenolate 500mg 2 in the morning - 2 in the evening
|
54 | $1,208.00 |
High-Quality Myasthenia Gravis PBMC for Research
Human Myasthenia Gravis PBMC products are sourced from donors clinically diagnosed with Myasthenia Gravis (MG) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies of autoreactive immune cells, cytokine profiling, and production of MG-associated antibodies.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed MG donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified MG diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional Myasthenia Gravis (MG)-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in MG pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Myasthenia Gravis (MG) PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.